VEGF is secreted by breast cancer cells in response to hypoxia to stimulate the angiogenesis necessary for continued cell proliferation and tumor growth [105] and contributes to breast cancer’s metastatic potential and apoptosis resistance [106,107]. This evidence concerns the gene VEGFA and breast carcinoma.